A UK neurologist who stumbled across a family with a gene mutation that can cause Lou Gehrig's Disease is merging science, medicine and family in a quest for a cure.
STAT News, a division of the Boston Globe, has published a story about the work of Dr. Edward Kasarskis and his team, who study a familial form of ALS.
The new Center for Health Equity Transformation aims to grow health equity research at the University of Kentucky by training and providing professional development guidance to those interested in studying and addressing health disparities.
A rare, genetic type of ALS seems to cluster in central Appalachia. The TRANSLATE clinical trial, led by a multidisciplinary time of clinicians and scientists, is looking for hope in an existing FDA-approved drug.
New findings from the University of Kentucky published in the Journal of Neuroscience demonstrate that there may be ways to address blood-brain barrier dysfunction in epilepsy.
A team of UK researchers have homed in on a protein, called RIT1, that may act as a master switch in the brain. A new five-year, $2.5 million grant from the National Institutes of Health will help them explore RIT1 as a possible target for treatments to counteract brain injury.
The third annual International Society of Neurogastronomy Symposium brought together experts from the worlds of food and neuroscience to explore what we eat and why.
Dr. Craig Van Horne, neurosurgeon, and Dr. George Quintero, DBS neurophysiologist at UK HealthCare's Neuroscience Institute, discuss deep brain stimulation in Sunday's Herald-Leader Your Health column.
Case Western Reserve and UK's SCoBIRC were able to show the existence of a parallel neural network that could potentially restore diaphragm function after spinal cord injury. Perhaps more amazing is that this research is credited to a group of young scientists.
